Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increases in serum sphingomyelin by 17 beta-estradiol.

A H Merrill, E Wang, W S Innis

    Lipids
    |April 1, 1985
    PubMed
    Summary

    Estrogen administration significantly increased plasma sphingomyelin, cholesterol, and triacylglycerol levels in chicks. Hepatic sphingomyelin synthesis enzyme activity remained unchanged, suggesting altered substrate supply or clearance affects lipid levels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.

    Cellular and molecular biology (Noisy-le-Grand, France)·2003
    Same author

    Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.

    Science's STKE : signal transduction knowledge environment·2001
    Same author

    Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china.

    Cancer causes & control : CCC·2001
    Same author

    Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.

    Biochemical Society transactions·2001
    Same author

    A cross-sectional study of human serum sphingolipids, diet and physiologic parameters.

    The Journal of nutrition·2001
    Same author

    Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.

    Cancer research·2001

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Lipid Metabolism

    Background:

    • Estrogens are known to influence lipid metabolism.
    • Sphingomyelin is a key component of cell membranes and lipoproteins.
    • Understanding estrogen's impact on sphingomyelin synthesis is crucial for metabolic research.

    Purpose of the Study:

    • To investigate the effects of 17 beta-estradiol on plasma sphingomyelin levels.
    • To examine the activity of serine palmitoyltransferase, the rate-limiting enzyme in sphingomyelin synthesis, in the liver.
    • To explore the relationship between estrogen, sphingomyelin, and other lipid pathways.

    Main Methods:

    • Immature chicks were administered 17 beta-estradiol for three days.
    • Plasma levels of sphingomyelin, total phospholipids, and cholesterol were measured.
    • Hepatic serine palmitoyltransferase (EC 2.3.1.50) activity was determined.
    • Liver weights and sphingomyelin content were analyzed.

    Main Results:

    • Serum sphingomyelin, total phospholipids, and cholesterol levels doubled.
    • Triacylglycerol levels increased 7.5-fold after estrogen treatment.
    • Hepatic sphingomyelin content and the specific activity of serine palmitoyltransferase were unaffected.
    • Increased liver weight led to a slight increase in total enzyme activity.

    Conclusions:

    • Estrogen-induced increases in plasma sphingomyelin are likely due to factors other than enhanced hepatic synthesis, such as substrate availability or reduced clearance.
    • These findings suggest a coordinated regulation of sphingomyelin, cholesterol, and glycerolipid biosynthesis pathways by estrogens.
    • Estrogen treatment may enhance very-low-density lipoprotein (VLDL) synthesis.

    Related Experiment Videos